A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

✍ Scribed by Myrna Candelaria; Dolores Gallardo-Rincón; Claudia Arce; Lucely Cetina; Jose Luis Aguilar-Ponce; Oscar Arrieta; Alberto Serrano; Carlos Perez-Plasencia; Aurora Gonzalez-Fierro; Erik de la Cruz-Hernandez; Alma Revilla-Vazquez; Alma Chavez-Blanco; Catalina Trejo-Becerril; Enrique Perez-Cardenas; Lucia Taja-Chayeb; Maria F Camargo; Elizabeth Robles; Alfonso Dueñas-Gonzalez

• Book ID: 115011187
• Publisher: BioMed Central
• Year: 2007
• Tongue: English
• Weight: 164 KB
• Volume: 7
• Category: Article
• ISSN: 1471-2407
• DOI: 10.1186/1471-2407-7-s1-a27